Rituximab Maintenance for Patients With Diffuse Large B-Cell Lymphoma in First Complete Remission: Results From a Randomized HOVON-Nordic Lymphoma Group Phase III Study

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2019年 / 17卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6 / 8
页数：3
相关论文
共 50 条
  • [31] Adaptive B cell responses in rituximab-treated diffuse large B cell lymphoma patients during complete remission
    Cha, Zhanshan
    Li, Chen
    Zang, Yan
    Gu, Haihui
    Guo, Huijun
    Li, Jinqi
    Fang, Yuan
    Petersen, Thomas F.
    Li, Jing
    Karas, Richard O.
    Hamilton, Michele L.
    Qian, Baohua
    TUMOR BIOLOGY, 2016, 37 (01) : 829 - 835
  • [32] Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort study
    Fukuta, Takanori
    Nishimura, Noriko
    Shirouchi, Yuko
    Inoue, Norihito
    Uryu, Hideki
    Kusano, Yoshiharu
    Mishima, Yuko
    Yokoyama, Masahiro
    Tsuyama, Naoko
    Takeuchi, Kengo
    Terui, Yasuhito
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (04) : 567 - 573
  • [33] Differences in Outcomes in Males and Females with Diffuse Large B-Cell Lymphoma with Induction Rituximab and Follicular Lymphoma Treated with Maintenance Rituximab
    Habermann, Thomas M.
    Hong, Fangxin
    Morrison, Vicki A.
    Dakhil, Shaker R.
    Weick, James K.
    Frankel, Stanley R.
    Gascoyne, Randy D.
    Fisher, Richard I.
    Cheson, Bruce D.
    Weller, Edie A.
    Kahl, Brad S.
    Peterson, Bruce A.
    Hochster, Howard S.
    Horning, Sandra J.
    BLOOD, 2012, 120 (21)
  • [34] A Case of Primary Adrenal Diffuse Large B-cell Lymphoma Achieving Complete Remission with Rituximab-CHOP Chemotherapy
    Kim, Kyung Min
    Yoon, Dok Hyun
    Lee, Seung Geun
    Lim, Sung Nam
    Sug, Lyu Jin
    Huh, Jooryung
    Suh, Cheolwon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (03) : 525 - 528
  • [35] Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study
    Strati, Paolo
    de Vos, Sven
    Ruan, Jia
    Maddocks, J. Kami
    Flowers, R. Christopher
    Rule, Simon
    Patel, Priti
    Xu, Yan
    Wei, Helen
    Frigault, M. Melanie
    Calvo, Roser
    Dyer, J. S. Martin
    HAEMATOLOGICA, 2021, 106 (10) : 2774 - 2778
  • [36] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    Habermann, Thomas M.
    Weller, Edie A.
    Morrison, Vicki A.
    Gascoyne, Randy D.
    Cassileth, Peter A.
    Cohn, Jeffrey B.
    Dakhil, Shaker R.
    Woda, Bruce
    Fisher, Richard I.
    Peterson, Bruce A.
    Horning, Sandra J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3121 - 3127
  • [37] Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
    Assouline, Sarit E.
    Nielsen, Torsten Holm
    Yu, Stephen
    Alcaide, Miguel
    Chong, Lauren
    MacDonald, David
    Tosikyan, Axel
    Kukreti, Vishal
    Kezouh, Abbas
    Petrogiannis-Haliotis, Tina
    Albuquerque, Marco
    Fornika, Daniel
    Alamouti, Sepideh
    Froment, Remi
    Greenwood, Celia M. T.
    Oros, Kathleen Klein
    Camglioglu, Errol
    Sharma, Ayushi
    Christodoulopoulos, Rosa
    Rousseau, Caroline
    Johnson, Nathalie
    Crump, Michael
    Morin, Ryan D.
    Mann, Koren K.
    BLOOD, 2016, 128 (02) : 185 - 194
  • [38] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    Habermann, T
    Weller, E
    Morrison, V
    Gascoyne, R
    Cassileth, P
    Cohn, J
    Dakhil, S
    Woda, B
    Fisher, R
    Peterson, B
    Horning, S
    ANNALS OF ONCOLOGY, 2005, 16 : 103 - 103
  • [39] A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
    Shi, Yuankai
    Song, Yongping
    Qin, Yan
    Zhang, Qingyuan
    Han, Xiaohong
    Hong, Xiaonan
    Wang, Dong
    Li, Wei
    Zhang, Yang
    Feng, Jifeng
    Yang, Jianmin
    Zhang, Huilai
    Jin, Chuan
    Yang, Yu
    Hu, Jianda
    Wang, Zhao
    Jin, Zhengming
    Su, Hang
    Wang, Huaqing
    Yang, Haiyan
    Fu, Weijun
    Zhang, Mingzhi
    Zhang, Xiaohong
    Chen, Yun
    Ke, Xiaoyan
    Liu, Li
    Yu, Ding
    Chen, Guo'an
    Wang, Xiuli
    Jin, Jie
    Sun, Tao
    Du, Xin
    Cheng, Ying
    Yi, Pingyong
    Zhao, Xielan
    Ma, Chaoming
    Cheng, Jiancheng
    Chai, Katherine
    Luk, Alvin
    Liu, Eugene
    Zhang, Xin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [40] A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
    Yuankai Shi
    Yongping Song
    Yan Qin
    Qingyuan Zhang
    Xiaohong Han
    Xiaonan Hong
    Dong Wang
    Wei Li
    Yang Zhang
    Jifeng Feng
    Jianmin Yang
    Huilai Zhang
    Chuan Jin
    Yu Yang
    Jianda Hu
    Zhao Wang
    Zhengming Jin
    Hang Su
    Huaqing Wang
    Haiyan Yang
    Weijun Fu
    Mingzhi Zhang
    Xiaohong Zhang
    Yun Chen
    Xiaoyan Ke
    Li Liu
    Ding Yu
    Guo’an Chen
    Xiuli Wang
    Jie Jin
    Tao Sun
    Xin Du
    Ying Cheng
    Pingyong Yi
    Xielan Zhao
    Chaoming Ma
    Jiancheng Cheng
    Katherine Chai
    Alvin Luk
    Eugene Liu
    Xin Zhang
    Journal of Hematology & Oncology, 13
12345